Concepedia

Nikhil Bhat

NB

Statistics

Publications

4

Citations

164

H-Index

4

Active since

2018

Affiliations

Hindustan Petroleum Corporation Limited (India)(Current)

Vellore Institute of Technology University

Nikhil Bhat is an author at Hindustan Petroleum Corporation Limited (India) specializing in cancer therapeutics, medicine, and nuclear medicine.

ORCID

Top concepts

Publications per year

2018–2021

4

Publications

4

Critical causes of time overrun in Indian construction projects and mitigation measures

K. V. Prasad, V. Vasugi, Nikhil Bhat · International Journal of Construction Education and Research · 2018 · 71 citations

Analysis of causes of delay in Indian construction projects and mitigation measures

K. V. Prasad, V. Vasugi, Nikhil Bhat · Journal of Financial Management of Property and Construction · 2019 · 62 citations

, , +18

A phase II trial of cabozantinib (CABO) for the treatment of radioiodine (RAI)-refractory differentiated thyroid carcinoma (DTC) in the first-line setting.

Marcia S. Brose, Sangeeta Shenoy, Nikhil Bhat et al. · Journal of Clinical Oncology · 2018 · 21 citations

, , +19

Impact of the Covid-19 pandemic on construction organisations in India: a case study

K. V. Prasad, Nikhil Bhat · Proceedings of the Institution of Civil Engineers - Civil Engineering · 2021 · 10 citations

1–4 of 4